FDAcategoryD
A designation by the US FDA signifying that there is positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience or studies in humans, but potential benefits may warrant use of the drug in pregnant women despite potential risks.
- A value of
- Drug
Pregnancy Category - Source
- Schema.org 30.1
- FDAcategoryA
- FDAcategoryB
- FDAcategoryC
- FDAcategoryD
- FDAcategoryX
- FDAnotEvaluated
More values of DrugPregnancyCategory
The 5 other values of Drug
- FDAcategory
A A designation by the US FDA signifying that adequate and well-controlled studies have failed to demonstrate a risk to the fetus in the first trimester of… - FDAcategory
B A designation by the US FDA signifying that animal reproduction studies have failed to demonstrate a risk to the fetus and there are no adequate and… - FDAcategory
C A designation by the US FDA signifying that animal reproduction studies have shown an adverse effect on the fetus and there are no adequate and well-controlled… - FDAcategory
X A designation by the US FDA signifying that studies in animals or humans have demonstrated fetal abnormalities and/or there is positive evidence of human fetal… - FDAnot
Evaluated A designation that the drug in question has not been assigned a pregnancy category designation by the US FDA.
Where this comes from
Copied word for word from Schema.org, and credited. Nothing in this definition is written by us.
- Published bySchema.orgschema.org/FDAcategory
D - ReleaseVersion 30.116 September 2026
- LicenseCC BY-SA 3.0Free to copy and adapt, with credit, under the same licence
- Changed by usNothing.
Use this value
Its definition is free to reuse, with credit to Schema.org. The same value is here as data, for programs and for language models.
Partner with us
Fund the next pass, contribute data, or build on the record. Tell us what you have in mind.
Partner with us